do athletes use bpc 157 The Truth About Peptide in Sports Medicine: What You Need to Know bpc 157 clinical trial results

In particular, a variant of approximately 20 kDa originated by an alternative splicing is present in a rather constant 1:9 ratio, [10] while recently an additional variant of ~ 23-24 kDa has also been reported in post-exercise states at higher proportions

It is administered either intramuscularly or subcutaneously

Safety data in humans is not as robust as it is for FDA approved medications

The existing evidence base comes from preclinical (animal) studies conducted primarily at Washington State University, where the compound was developed and patented for potential use in Alzheimer's disease

It may also aid in enhancing cognitive function and reducing symptoms of neurological disorders like Parkinsons disease